Hopec Pharma
General Data
Reg Number
516759495
Sector
Biomed
Established
2023
No. of Employees
5
Stage
R&D
Additional Funding
1
Description
Hopec Pharma is a clinical-stage biotech company developing a first-in-class immunotherapy for non-muscle invasive bladder cancer (NMIBC). Our therapy is based on a proprietary attenuated E. coli strain designed to stimulate a targeted immune respons
Technology
A non-muscle-invasive bladder that employs genetically modified uropathogenic coli for targeted immune responses against cells, enabling patients to to destroy cancer cells.
Targeted Customers
Oncologists, hospitals.
Management personnel
Gadi Klarsfeld - CEO & Co-Founder
Winning details
Route name
Winning year
Startup Fund
Startup Fund
2025